• OPEN AN ACCOUNT
Indian Indices
Nifty
24,722.75 157.40
(0.64%)
Sensex
81,018.72 418.81
( 0.52%)
Bank Nifty
55,619.35 1.75
( 0.00%)
Nifty IT
35,203.35 553.75
( 1.60%)
Global Indices
Nasdaq
43,604.51 -547.48
(-1.24%)
Dow Jones
6,258.79 -101.60
(1.60%)
Hang Seng
40,307.27 -492.33
(-1.21%)
Nikkei 225
9,068.58 -64.23
(-0.70%)
Forex
USD-INR
87.57 0.14
(0.16%)
EUR-INR
100.09 -0.48
(-0.48%)
GBP-INR
115.87 -0.55
(-0.47%)
JPY-INR
0.58 0.00
(-0.74%)

EQUITY - MARKET SCREENER

Panjon Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526345
INE744D01019
9.6387899
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
59.19
31.5
EPS(TTM)
Face Value()
Div & Yield %
0.31
10
0
 

RRIL consolidated net profit rises 14.86% in the March 2025 quarter
May 24,2025
Net profit of RRIL rose 14.86% to Rs 2.01 crore in the quarter ended March 2025 as against Rs 1.75 crore during the previous quarter ended March 2024. Sales rose 16.27% to Rs 30.51 crore in the quarter ended March 2025 as against Rs 26.24 crore during the previous quarter ended March 2024.

For the full year,net profit rose 18.72% to Rs 6.85 crore in the year ended March 2025 as against Rs 5.77 crore during the previous year ended March 2024. Sales rose 18.54% to Rs 112.86 crore in the year ended March 2025 as against Rs 95.21 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales30.5126.24 16 112.8695.21 19
OPM %10.035.72 -7.406.31 -
PBDT3.442.72 26 10.688.88 20
PBT3.032.56 18 9.617.71 25
NP2.011.75 15 6.855.77 19